Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human DTX1 ELISA Kit (AC2968)
Cat.#: ASET-1557
Specifications
Description Human DTX1 ELISA Kit allows for the in vitro quantitative determination of human DTX1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-1872 Human 5HT1A Receptor ELISA Kit (AC3283) Quantitative inquiry ASET-1399 Mouse alpha 2a Adrenergic Receptor ELISA Kit (AC2810) Quantitative inquiry ASET-1912 Rat NMDAR1 ELISA Kit (AC3323) Quantitative inquiry ASET-1764 Human NRG1 ELISA Kit (AC3175) Quantitative inquiry ASET-2097 Mouse Estrogen Receptor beta ELISA Kit (AC3508) Quantitative inquiry ASET-2526 Human Estrogen Receptor alpha ELISA Kit (AC3937) Quantitative inquiry ASET-1791 Human CAPS1 ELISA Kit (AC3202) Quantitative inquiry ASET-1705 Rat Galanin ELISA Kit (AC3116) Quantitative inquiry ASET-2146 Human PTF1A ELISA Kit (AC3557) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket